BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20403430)

  • 1. Lactosaminated human albumin, a hepatotropic carrier of drugs.
    Fiume L; Di Stefano G
    Eur J Pharm Sci; 2010 Jul; 40(4):253-62. PubMed ID: 20403430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis.
    Fiume L; Verme G
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):275-80. PubMed ID: 9646223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes.
    Jansen RW; Kruijt JK; van Berkel TJ; Meijer DK
    Hepatology; 1993 Jul; 18(1):146-52. PubMed ID: 7686877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver targeting of adenine arabinoside monophosphate (ara-AMP) by coupling to lactosaminated human serum albumin.
    Fiume L; Busi C; Di Stefano G; Mattioli A; Torrani-Cerenzia M; Bonino F; Capra G; De Bernardi W; Ponzetto A; Lavezzo B
    Ital J Gastroenterol; 1995 May; 27(4):189-92. PubMed ID: 8520036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
    Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
    J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade.
    Di Stefano G; Fiume L; Baglioni M; Bolondi L; Busi C; Chieco P; Kratz F; Manaresi F; Pariali M
    Liver Int; 2006 Aug; 26(6):726-33. PubMed ID: 16842330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
    Di Stefano G; Derenzini M; Kratz F; Lanza M; Fiume L
    Liver Int; 2004 Jun; 24(3):246-52. PubMed ID: 15189276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor.
    Fiume L; Di Stefano G; Busi C; Mattioli A; Bonino F; Torrani-Cerenzia M; Verme G; Rapicetta M; Bertini M; Gervasi GB
    J Viral Hepat; 1997; 4(6):363-70. PubMed ID: 9430355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
    Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
    Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on asialoglycoprotein receptor mediated endocytosis of antiviral conjugate].
    Ju L; Huang-fu Y; Zhang L
    Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):124-7. PubMed ID: 8758445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier.
    Di Stefano G; Kratz F; Lanza M; Fiume L
    Dig Liver Dis; 2003 Jun; 35(6):428-33. PubMed ID: 12868680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Bolondi L; Farina C; Mori F; Chieco P; Pariali M; Kratz F; Molin L; Salmaso S; Caliceti P
    Eur J Pharm Sci; 2008 Feb; 33(2):191-8. PubMed ID: 18201877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
    Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
    Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.
    Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-L-lysine coupling: implications for regional chemotherapy of hepatic micrometastases.
    Di Stefano G; Busi C; Camerino A; Nardo B; Fiume L
    Biochem Pharmacol; 2000 Feb; 59(3):301-4. PubMed ID: 10609559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
    Torrani Cerenzia M; Fiume L; De Bernardi Venon W; Lavezzo B; Brunetto MR; Ponzetto A; Di Stefano G; Busi C; Mattioli A; Gervasi GB; Bonino F; Verme G
    Hepatology; 1996 Apr; 23(4):657-61. PubMed ID: 8666314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.